Obesity, a growing global epidemic, is identified as a significant, modifiable risk factor for ovarian cancer, a deadly gynecologic malignancy often diagnosed late. Research indicates that increased ...

If you have ovarian cancer, there’s a good chance that at some point you’ll experience a complication — a problem or side effect of either the disease or treatment. (1) These complications ...

Cytoreductive surgery and advances in systemic therapy have improved the prognosis of primary advanced ovarian cancer and the therapeutic aim has shifted from a palliative situation to cure or at ...

HealthDay News — A model with eight independent risk factors can predict the risk for deep vein thrombosis (DVT) in patients with epithelial ovarian cancer (EOC), according to a study published online ...

In a twist no one expected, researchers found that many HV tumors express CA125, a marker known for its role in ovarian cancer. This means that 1 in 4 bladder cancer cases may be hiding this ...

We examined variation by age, sex, deprivation, and time following presentation. Findings Of 250,606 patients presenting with fatigue, 12-month cancer risk exceeded 3% in men aged 65 and over and ...

IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025 Provided by GlobeNewswire Jun 18, 2025, 5:05:00 AM ...

Following her stage 3C ovarian cancer diagnosis, Stephens’ team of doctors scheduled a radical hysterectomy and 6 rounds of chemotherapy with Sobia Ozair, MD, at Our Lady of the Lake.

Session ID: 2025-06-28:6adbb0cf66cf1dfca36b4b5e Player Element ID: Ve269e51d_e4d5_4feb_b17c_388708de9ffa_6374460531112 ...

Session ID: 2025-07-05:a9ece43781ac7e12d6a167fc Player Element ID: V81c58387_cfb1_491d_bba5_1e16fe4fb7b1_6374461101112 ...

The Lancet publication and the IGCS presentation disclosed that cadonilimab, in combination with platinum-based chemotherapy (with or without bevacizumab), significantly extended survival in both ...